Pancreatic Cancer Research

Clinical trialNo phase (not a drug trial)Terminated

Preoperative Prehabilitation for Sarcopenic Patients Prior to Pancreatic Surgery for Cancer

Prehabilitaion Program for Sarcopenic Patients Prior to Pancreaticoduodenectomy for Periampullary Malignant Tumors

Outcome
Stopped earlyThe study was terminated prematurely due to patient inclusion difficulties. (Enrollment)
Phase
No phase (not a drug trial)
Status
Terminated
Study type
Interventional
Start
17 May 2022
Ended
17 June 2025
Enrollment
6 participants
Sites
1
Primary outcomes
Post-operative severe pancreatic fistula (Grade B and C)
Sponsor type
Academic / other
Results posted
No
Last update
14 July 2026

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

Major digestive surgery is associated with a significant rate of postoperative complications. To improve postoperative outcome, efforts are focused on postoperative course leading to the concept of rehabilitation. However, the rehabilitation concept does not allow to improve muscular and functional reserves at the time of surgery. Sarcopenia is a condition characterized by loss of skeletal muscle mass and function. Also, the prevalence of sarcopenia in patients with cancer is high and has a prevalence of around 25% in patients with pancreatic cancer, with a considerable impact on postoperative and survival outcomes. The hypothesis is the preoperative management of sarcopenia by a rehabilitation program could improve patients' operative outcomes by reducing the rate of postoperative complications.